EcoR1 Capital, LLC
Source: SEC Form 13F · as of Mar 2026EcoR1 Capital, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $1.74B in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$1.74B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Zymeworks Inc. (ZYME)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ZYMEZymeworks Inc. | 22,970,388 | $575.2M |
| ANABANAPTYSBIO, INC | 7,880,094 | $437.0M |
| JAZZJazz Pharmaceuticals plc | 1,706,469 | $322.6M |
| CNTACentessa Pharmaceuticals plc | 6,000,000 | $238.3M |
| ORICOric Pharmaceuticals, Inc. | 6,728,116 | $85.2M |
| NGNENeurogene Inc. | 1,271,342 | $25.6M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 2,823,126 | $25.3M |
| ZBIOZenas BioPharma, Inc. | 789,500 | $15.4M |
| ZURAZura Bio Ltd | 1,179,715 | $7.0M |
| STOKStoke Therapeutics, Inc. | 100,000 | $3.3M |
| PRLDPrelude Therapeutics Inc | 947,049 | $3.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.